Shuai Dong

Years Active: 2020-2021
Publications (10 Years): 2

Dana Farber Cancer Institute

Ohio State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute Sep 04 2018

United States

Research Fellow :: Medical Oncology

Education History

Ohio State University Aug 26 2011 - Dec 17 2017

United States

PHD :: Pharmaceutics and Pharmaceutical Chemistry

Publications

Ishwarya Murali, Siddha Kasar, Aishath Naeem, Svitlana Tyekucheva, Jasneet Kaur Khalsa, Emily M Thrash, Gilad Itchaki, Dimitri Livitz, Ignaty Leshchiner, Shuai Dong, Stacey M Fernandes, Gad Getz, Amy Johnson, Jennifer R Brown
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia. Blood 138 (1) (2021)
Shaneice R Mitchell, Karilyn T M Larkin, Nicole R Grieselhuber, Tzung-Huei Lai, Matthew Cannon, Shelley Orwick, Pratibha Sharma, Yerdanose Asemelash, Pu Zhang, Virginia M Goettl, Larry Beaver, Alice Mims, Vinay K Puduvalli, James S Blachly, Amy Lehman, Bonnie K Harrington, Sally Henderson, Justin T Breitbach, Katie E Williams, Shuai Dong, Erkan Baloglu, William Senapedis, Karl N Kirschner, Deepa Sampath, Rosa Lapalombella, John C Byrd
Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia. Blood advances 3 (3) (2020)

Shuai Dong.css-eqlu8i{font-size:small;padding-left:4px;}